Vanguard Fiduciary Trust
INBS icon

Vanguard Fiduciary Trust’s Intelligent Bio Solutions INBS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.08K Hold
3,958
– – ﹤0.01% 4045
2026
Q1 		$13.2K Buy
+3,958
New +$27.3K ﹤0.01% 3981

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Fiduciary Trust's INBS Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Intelligent Bio Solutions (INBS) position steady in Q2 2026 at 3,958 shares worth $9.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

Vanguard Fiduciary Trust first reported a position in INBS in Q1 2026 and has held it in 2 quarters since. The position peaked at $13.2K in Q1 2026. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Vanguard Fiduciary Trust held 3,958 shares of Intelligent Bio Solutions worth $9.08K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Intelligent Bio Solutions share count unchanged in Q2 2026.
  • Intelligent Bio Solutions made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4045 holding.
  • Vanguard Fiduciary Trust first reported a position in Intelligent Bio Solutions in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Intelligent Bio Solutions position peaked at $13.2K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.